Dual oxidases (DUOX1 and DUOX2) are evolutionary conserved reduced nicotinamide adenine
dinucleotide phosphate oxidases responsible for regulated hydrogen peroxide (H 2 O 2 …

Three‐drug induction regimens have become the standard of care in newly diagnosed
transplant‐eligible multiple myeloma patients. Two frequently used protocols are bortezomib, …

LBA11504 Background: Cabozantinib (C) has been combined successfully with either PD-1
or CTLA-4 inhibition in cancer clinical trials. The combination of nivolumab (N) and …

Opinion statement Synovial sarcoma (SS) is a fusion-driven subtype of sarcoma that is a more
chemo-sensitive subtype of soft tissue sarcoma. While chemotherapy options are currently …

Background: Sarcomas are a rare and heterogeneous tumor group composed of a variety of
histologic subtypes. Targeted next-generation sequencing (NGS) of bone and soft tissue …

Context: TSH receptor (TSHR) and thyroid peroxidase (TPO) gene mutations occur
independently. This is the first report of their coexistence in the same individuals. Objectives: The …

Background: Perivascular epithelioid cell neoplasms (PEComas) are a diverse family of
mesenchymal tumors with myomelanocytic differentiation that disproportionately affect women …

The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex
management. At a single institution, multidisciplinary teams of specialists determine and …

Introduction: β-thalassemia is a genetic blood disorder in which defective β-globin synthesis
leads to ineffective erythropoiesis. Patients with transfusion-dependent β-thalassemia …

Dedifferentiated liposarcoma (DDLPS) has an appealing therapeutic target due to its CDK4
amplification on chromosome 12q. The understanding of geroconversion from quiescent …